Physician profile
Anthony Mcbride
NPI 1598707465
$1,830.87
in general payments reported to CMS, 2019-2025
29 companies · $184 in 2025
The $184 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $730 · 2020: $74.44 · 2021: $347 · 2022: $161 · 2023: $184 · 2024: $151 · 2025: $184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $519.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $518.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $319.98 | 2019-2025 | Oxford, Persona, Bactisure |
| Amgen INC. | $254.34 | 2019-2024 | Prolia, Evenity |
| Stryker Corporation | $236.77 | 2019-2024 | Omega, Alphavent, Crossflow |
| Radius Health, INC. | $136.27 | 2019-2025 | Tymlos |
| Smith+Nephew, INC. | $116.42 | 2019-2021 | |
| Medical Device Business Services, INC. | $72.45 | 2019 | |
| Pacira Therapeutics, INC. | $70.66 | 2021 | |
| Arthrosurface Incorporated | $67.61 | 2019 | |
| Polynovo North America LLC | $51.85 | 2023-2024 | Novosorb Btm |
| Avanos Medical | $41.97 | 2019-2024 | Coolief* Cooled Radiofrequency |
| Djo, LLC | $40.55 | 2019 | |
| Ferring Pharmaceuticals INC. | $40.02 | 2024-2025 | Euflexxa |
| Pacira Pharmaceuticals Incorporated | $36.23 | 2020-2021 | |
| Nevro Corp. | $35.99 | 2023 | Senza |
| Depuy Synthes Sales INC. | $35.29 | 2019-2020 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $33.38 | 2019-2023 | Xiaflex |
| Skeletal Dynamics INC | $32.72 | 2024 | Geminus, Ijs, Align |
| Si-Bone, INC. | $28.74 | 2021 | |
| Organogenesis INC. | $23.83 | 2025 | Puraply Wound Matrix |
| Pfizer INC. | $23.22 | 2019 | |
| Vericel Corporation | $20.93 | 2025 | Maci |
| Heron Therapeutics, INC. | $20.00 | 2021 | |
| Abbvie INC. | $16.42 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $15.55 | 2025 | |
| Integra Lifesciences Corporation | $12.93 | 2019 | |
| Paratek Pharmaceuticals, INC. | $12.74 | 2023 | Nuzyra |
| Kci USA, INC. | $12.72 | 2019 | |
| Sanofi-Aventis U.S. LLC | $11.56 | 2019 | |
| Orthofix Medical, INC. | $9.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Mcbride listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.